Virtu Financial’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,335
Closed -$731K 2323
2020
Q4
$731K Sell
6,335
-663
-9% -$74.3K 0.08% 319
2020
Q3
$681K Buy
+6,998
New +$805K 0.12% 201
2019
Q4
$438K Buy
4,191
+353
+9% +$39.6K 0.04% 480
2019
Q3
$441K Buy
3,838
+1,912
+99% +$290K 0.03% 564
2019
Q2
$332K Buy
+1,926
New +$333K 0.02% 733
2019
Q1
Sell
-7,574
Closed -$738K 2047
2018
Q4
$738K Buy
7,574
+3,169
+72% +$416K 0.04% 354
2018
Q3
$761K Buy
4,405
+2,911
+195% +$420K 0.05% 424
2018
Q2
$208K Buy
+1,494
New +$212K 0.01% 1482
2018
Q1
Sell
-15,893
Closed -$2.1M 2877
2017
Q4
$2.1M Sell
15,893
-2,159
-12% -$254K 0.11% 173
2017
Q3
$1.83M Buy
+18,052
New +$1.93M 0.09% 202

Other funds holding GWPH

Virtu Financial's GWPH Position: Q1 2021 in Review

Virtu Financial sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 6,335 shares — an estimated $731K sold.

Virtu Financial first reported a position in GWPH in Q3 2017 and held it in 10 quarters. The position peaked at $2.1M in Q4 2017. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Virtu Financial reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Virtu Financial sold 6,335 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $731K.
  • Virtu Financial first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 10 quarters.
  • Virtu Financial's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.1M in Q4 2017.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Virtu Financial's 13F filing for Q1 2021, filed 19 May 2021.